
By NATASHA SINGER
Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say.
Published: April 14, 2018 at 07:00PM
from NYT Technology https://ift.tt/2vkhksw
via IFTTT